Corbus Pharmaceuticals Holdings, Inc. (0SZI.L) LSE

9.39

-0.131(-1.38%)

Updated at August 18 04:51PM

Currency In USD

Valuation

Market Cap128.8M
Enterprise Value114.84M
P/E Ratio-1.95
PEG Ratio-0.06
Price/Sales Ratio0
Price/Book Ratio1.02
Enterprise/Revenue0
Enterprise/EBITDA-2.42

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.46
Return On Equity-0.44

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-37.74M
Net Income-40.21M
Diluted EPS-3.68

Balance Sheet

Total Cash20.04M
Total Cash/Share1.64
Total Debt2.46M
Total Debt/Equity0.02
Current Ratio9.21
Book Value Per Share9.07

Price History

52-Week Change-82.97
52-Week High49.65
52-Week Low2.82
Moving Average 50 Days21.54
Moving Average 200 Days10.76

Statistics

Average Volume3,322
Shares Outstanding12.26M
% Held by Institutions85.64

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:30
Last Split DateFebruary 23, 2023